THOMAS GRIFFITH: Open Payments
NPI 1013681113 · LONG BEACH, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,264 in 53 payments from 13 companies in 2025. Trend: 2023 $1,062 · 2024 $1,365 · 2025 $1,264
Food & beverage: $1,264
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 14 | $337 |
| ABBVIE INC. | 9 | $167 |
| Indivior Inc. | 2 | $153 |
| Alkermes, Inc. | 6 | $123 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Axsome Therapeutics, Inc. | 3 | $83 |
| Braeburn Inc. | 3 | $76 |
| Teva Pharmaceuticals USA, Inc. | 3 | $55 |
| Janssen Pharmaceuticals, Inc | 2 | $47 |
| Lundbeck LLC | 2 | $46 |
Products named: INGREZZA, VRAYLAR, SUBLOCADE, COBENFY, Auvelity, ARISTADA, BRIXADI, REXULTI.
Industry payments across NY — which companies pay providers there.
